News

DoH targets prevalence 'damping' and QOF in funding review

03-Jul-08

Funding is to be redirected to practices in areas of high disease prevalence, the government has announced.

National director of primary care Dr David Colin-Thome said that the prevalence formula and MPIG were ‘the two things working against getting money to where it's needed'.

When the new GMS contract was negotiated, he said, ‘we damped down the role of prevalence. We want to remove that.'

Dr Colin-Thome was speaking at the launch of the new national primary care strategy at the DoH's Richmond House headquarters in Whitehall this morning.

He also said that the government would like to treble the proportion of quality framework funding spent on preventative care, from 5 per cent to 15 per cent.

Although the Darzi review promises to give patients a wider choice of GP, practices will not be forced to widen their boundaries.

But where surveys found patient choice was poor, PCTs will be ‘encouraged to find alternative providers', he said.

jonn.elledge@haymarket.com

DoH Primary Care Strategy

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Search MIMS Database

 
 

Latest Clinical Articles

Altitude-related illness

Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more

Clinical Review - Subfertility in women

Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more

Stable angina pectoris

Contributed by Dr Unni Krishnan, clinical research fellow in cardiology at the Glenfield Hospital, L... Read more

Show all clinical articles

MIMS Product News

Relistor

New drug - Relistor

Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more

Thalidomide available in the UK

Thalidomide, under the name of Thalidomide Pharmion is now commercially available in the UK. Read more

MMR catch-up programme

The DoH has written to healthcare professionals to call for urgent action to help reduce the risk of... Read more

Jobs

 

Job of the Week